Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 4551-4600 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT06057571
Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor
PHASE2
Active, not recruiting
50 participants
Started: Nov 17, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
29 locations
NCT06680765
An Evaluation of the Effectiveness of a Maternal, Neonatal and Child Health Component for Matasa Matan Arewa and Smart Start Targeting Married Adolescent Girls in Nigeria and Ethiopia
NA
Active, not recruiting
2,338 participants
Started: Nov 17, 2023 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT05856695
Durvalumab Plus Etoposide-free Chemotherapy in First-line Treatment of Extensive-disease Small-sell Lung Cancer (SCLC)
PHASE2
Active, not recruiting
67 participants
Started: Nov 17, 2023 · Completed: Feb 29, 2028
1 condition
1 sponsor
31 locations
NCT05762393
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar
PHASE1
Active, not recruiting
120 participants
Started: Nov 17, 2023 · Completed: May 31, 2025
1 condition
1 sponsor
2 locations
NCT05970224
A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage
PHASE2
Active, not recruiting
23 participants
Started: Nov 17, 2023 · Completed: Jul 31, 2027
1 condition
1 sponsor
10 locations
NCT06101329
Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)
PHASE2
Active, not recruiting
253 participants
Started: Nov 17, 2023 · Completed: Jan 31, 2028
1 condition
2 sponsors
11 locations
NCT06833723
Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes
N/A
Active, not recruiting
1,000 participants
Started: Nov 17, 2023 · Completed: Nov 17, 2025
1 condition
1 sponsor
1 location
NCT06145412
A Study of Xevinapant With Cisplatin and Radiation Therapy After Surgery in People With Head and Neck Cancer
PHASE2
Active, not recruiting
4 participants
Started: Nov 16, 2023 · Completed: Nov 30, 2026
1 condition
1 sponsor
7 locations
NCT05999799
A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis
PHASE2
Active, not recruiting
163 participants
Started: Nov 16, 2023 · Completed: Jul 24, 2025
1 condition
1 sponsor
92 locations
NCT07091890
Effects of Topical Fluoride in Orthodontic Patients
NA
Active, not recruiting
60 participants
Started: Nov 16, 2023 · Completed: Nov 30, 2025
4 conditions
1 sponsor
1 location
NCT06126796
Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)
N/A
Active, not recruiting
107 participants
Started: Nov 16, 2023 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT05931302
Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT
NA
Active, not recruiting
40 participants
Started: Nov 16, 2023 · Completed: Nov 30, 2026
1 condition
3 sponsors
1 location
NCT06091943
Study to Evaluate the Bioavailability of Tislelizumab Via Subcutaneous Injection in First-Line Treatment of Participants With Advanced or Metastatic Non-Small Cell Lung Cancer
PHASE1
Active, not recruiting
62 participants
Started: Nov 16, 2023 · Completed: Jul 31, 2026
1 condition
1 sponsor
15 locations
NCT06170554
Study of Hydration Levels in Sports and Non-sports Schoolchildren (EHC)
N/A
Active, not recruiting
259 participants
Started: Nov 16, 2023 · Completed: Oct 31, 2024
1 condition
1 sponsor
1 location
NCT06153108
Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time
N/A
Active, not recruiting
20 participants
Started: Nov 16, 2023 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT06020014
Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
PHASE2
Active, not recruiting
340 participants
Started: Nov 16, 2023 · Completed: Oct 30, 2025
1 condition
1 sponsor
124 locations
NCT06189534
Cognitive Behavior Therapy for Social Media Addiction, Insomnia, and Family Relationship Among Individuals With Social Media Addiction: A Randomized Control Tria
NA
Active, not recruiting
150 participants
Started: Nov 15, 2023 · Completed: Apr 10, 2024
1 condition
1 sponsor
1 location
NCT06136741
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis
PHASE2
Active, not recruiting
396 participants
Started: Nov 15, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
107 locations
NCT06063967
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
PHASE3
Active, not recruiting
289 participants
Started: Nov 15, 2023 · Completed: Mar 31, 2027
1 condition
1 sponsor
179 locations
NCT06076499
A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS
N/A
Active, not recruiting
325 participants
Started: Nov 15, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
6 locations
NCT06049797
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
N/A
Active, not recruiting
998 participants
Started: Nov 15, 2023 · Completed: May 31, 2026
1 condition
1 sponsor
48 locations
NCT06069102
Optimal Blood Pressure Treatment Thresholds Postpartum
PHASE4
Active, not recruiting
60 participants
Started: Nov 15, 2023 · Completed: Dec 1, 2025
11 conditions
1 sponsor
1 location
NCT06042478
Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.
PHASE3
Active, not recruiting
470 participants
Started: Nov 15, 2023 · Completed: Jul 20, 2027
1 condition
1 sponsor
111 locations
NCT06106256
Three-Axis Wearable Adaptive Vestibular Stimulator
NA
Active, not recruiting
40 participants
Started: Nov 15, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06143046
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers
PHASE2
Active, not recruiting
360 participants
Started: Nov 15, 2023 · Completed: Feb 18, 2026
1 condition
1 sponsor
56 locations
NCT06281392
Artificial Intelligence and Dysplasia Detection in Inflammatory Bowel Disease (EIIDISIA Study)
NA
Active, not recruiting
122 participants
Started: Nov 15, 2023 · Completed: Nov 20, 2025
2 conditions
2 sponsors
1 location
NCT06208111
A Clinical Trial of Cognitive Behavior Therapy for Depression, Stigmatization, Excessive Worries, and Emotional Management Among Women Facing Partner Violence
NA
Active, not recruiting
180 participants
Started: Nov 15, 2023 · Completed: Apr 10, 2024
1 condition
1 sponsor
1 location
NCT06115967
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy Participants
PHASE1
Active, not recruiting
40 participants
Started: Nov 15, 2023 · Completed: Mar 30, 2026
1 condition
1 sponsor
2 locations
NCT06226896
Effects of Dapagliflozin on Progression of Alport Syndrome
N/A
Active, not recruiting
222 participants
Started: Nov 15, 2023 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT06157177
Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
PHASE4
Active, not recruiting
50 participants
Started: Nov 15, 2023 · Completed: Nov 15, 2025
2 conditions
2 sponsors
19 locations
NCT06190106
Experiences of Psychotherapeutic Outcomes in Women Victims of Domestic Violence
NA
Active, not recruiting
15 participants
Started: Nov 15, 2023 · Completed: Apr 10, 2024
1 condition
1 sponsor
1 location
NCT05882071
Non-interventional Study (NIS) on Sodium-glucose Co-transporter-2 Inhibitors (SGLT2i) Use in France
N/A
Active, not recruiting
547,150 participants
Started: Nov 15, 2023 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT06178705
Parenting Program for Parents of Children With Emotional and Behavioral Issues: A Randomized Control Trial
NA
Active, not recruiting
200 participants
Started: Nov 15, 2023 · Completed: Apr 10, 2024
1 condition
1 sponsor
1 location
NCT06168097
The Use of MicroRNAs Dysregulation as Potential Biomarkers for Effective Diagnosis of Endometriosis
NA
Active, not recruiting
200 participants
Started: Nov 15, 2023 · Completed: Dec 15, 2026
1 condition
1 sponsor
1 location
NCT06025877
Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey
N/A
Active, not recruiting
400 participants
Started: Nov 15, 2023 · Completed: Apr 30, 2025
6 conditions
1 sponsor
9 locations
NCT06175195
Psychoeducational Program for Cancer Patients.
NA
Active, not recruiting
200 participants
Started: Nov 15, 2023 · Completed: Apr 10, 2024
1 condition
1 sponsor
1 location
NCT06192043
Cognitive Behavioral Interventions for Motivation, Psychological Distress and Quality of Life Among Individuals With Smoking Cessation: A Randomized Control Trial
NA
Active, not recruiting
60 participants
Started: Nov 15, 2023 · Completed: Apr 10, 2024
1 condition
1 sponsor
1 location
NCT06199700
Esketamine for the Treatment of Rett Syndrome
EARLY_PHASE1
Active, not recruiting
3 participants
Started: Nov 15, 2023 · Completed: May 1, 2025
1 condition
1 sponsor
1 location
NCT06106828
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease
PHASE3
Active, not recruiting
127 participants
Started: Nov 15, 2023 · Completed: Jul 1, 2026
1 condition
1 sponsor
41 locations
NCT06097364
A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma
PHASE3
Active, not recruiting
733 participants
Started: Nov 14, 2023 · Completed: Jul 29, 2029
1 condition
1 sponsor
144 locations
NCT06369194
POWER AUDIT, Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol
N/A
Active, not recruiting
847 participants
Started: Nov 14, 2023 · Completed: Apr 15, 2024
5 conditions
1 sponsor
36 locations
NCT06104449
A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)
PHASE1
Active, not recruiting
6 participants
Started: Nov 14, 2023 · Completed: Apr 12, 2026
2 conditions
2 sponsors
3 locations
NCT06003231
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
PHASE2
Active, not recruiting
120 participants
Started: Nov 14, 2023 · Completed: May 31, 2028
4 conditions
1 sponsor
92 locations
NCT06102876
Feasibility of Physical Activity in Older Adults With Haematological Malignancies: ACCES Study
N/A
Active, not recruiting
69 participants
Started: Nov 14, 2023 · Completed: Sep 30, 2025
2 conditions
1 sponsor
1 location
NCT06019767
Peer-led Trauma Therapy for Re-entry
NA
Active, not recruiting
72 participants
Started: Nov 14, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05668390
Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma
PHASE3
Active, not recruiting
699 participants
Started: Nov 14, 2023 · Completed: Nov 30, 2025
2 conditions
1 sponsor
62 locations
NCT06062420
A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202
PHASE2
Active, not recruiting
316 participants
Started: Nov 14, 2023 · Completed: Jul 27, 2027
1 condition
2 sponsors
113 locations
NCT06112379
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer
PHASE3
Active, not recruiting
1,902 participants
Started: Nov 14, 2023 · Completed: Sep 23, 2032
1 condition
2 sponsors
283 locations
NCT06382688
IV Administration of ChromaDex's Niagen® as Compared to NAD+
NA
Active, not recruiting
53 participants
Started: Nov 13, 2023 · Completed: Aug 31, 2024
1 condition
1 sponsor
1 location
NCT06140693
A Comparison of Affective Responses During Continuous and Interval Exercise
NA
Active, not recruiting
29 participants
Started: Nov 13, 2023 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
89
90
91
92
93
94
95
More pages
431
Next